Statistics In the Pharmaceutical Industry
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
Januar 2023, ca. 496 Seiten, Chapman & Hall/CRC Biostatistics Series, Englisch
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Updated and expanded to reflect the recent trends and challenges in pharmaceutical statistics, this third edition presents chapters written by experts from both regulatory agencies and pharmaceutical companies.
Januar 2023, ca. 496 Seiten, Chapman & Hall/CRC Biostatistics Series, Englisch
Taylor and Francis
978-1-03-247787-9
Taylor and Francis
978-1-03-247787-9
Weitere Titel der Reihe: Chapman & Hall/CRC Biostatistics Series
Alle anzeigenMedical Statistics for Cancer Studies
Taylor and Francis, 2024
978-1-032-28587-0
79.00 CHF
sofort lieferbar
Statistical Analytics for Health Data Science with SAS and R
Taylor and Francis, 2023
978-1-03-232562-0
ca. 140.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Methods in Health Economics
Taylor and Francis, 2023
978-1-03-247753-4
ca. 80.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Data Science, AI, and Machine Learning in Drug Development
Taylor and Francis, 2022
978-0-367-70807-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2020
978-0-367-73187-8
ca. 86.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Artificial Intelligence for Drug Development, Precision Medicine, and Healthcare
Taylor and Francis, 2020
978-0-367-36292-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Bayesian Cost-Effectiveness Analysis of Medical Treatments
Taylor and Francis, 2019
978-1-138-73173-8
ca. 206.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Design & Analysis of Clinical Trials for Economic Evaluation & Reimbursement
An Applied Approach Using SAS & STATA
Taylor and Francis, 2015
978-1-4665-0547-6
ca. 146.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Benefit-Risk Assessment in Pharmaceutical Research and Development
Taylor and Francis, 2013
978-1-4398-6794-5
ca. 156.00 CHF
lieferbar in ca. 10-20 Arbeitstagen
Weitere Titel zum Thema
Variably Legal Markets
Rethinking Markets and Crime
Taylor and Francis, 2026
978-0-367-18613-5
ca. 249.00 CHF
erscheint im März
Multi-Criteria Decision-Making
Principles, Methods and Programs
Taylor and Francis, 2026
978-1-032-85363-5
ca. 159.00 CHF
erscheint im März
Engineered Biomaterials for Drug Delivery
Elsevier, 2026
978-0-323-95751-9
ca. 308.00 CHF
erscheint im Juli
Mitochondria-targeted Drug Delivery Strategies for Cancer Therapy
Elsevier, 2026
978-0-443-40479-5
ca. 275.00 CHF
erscheint im Juli
Drafting Agreements in Life Sciences
Bloomsbury, 2027
978-1-5265-3241-1
ca. 769.00 CHF
erscheint im Januar
Sustainable Financial Structured Products
Managing Risk Appetites across Modelling, Structuring, and Hedging
Taylor and Francis, 2026
978-1-032-65887-2
ca. 315.00 CHF
erscheint im Mai
Decision-Making and Analytics
Data-Driven Business Intelligence and Optimization
Taylor and Francis, 2026
978-1-041-23733-4
ca. 159.00 CHF
erscheint im Juli
Derivatives
Mathematical Foundations for Finance Students
Taylor and Francis, 2026
978-1-032-76218-0
ca. 99.00 CHF
erscheint im Juni
Discrete Choice Models
Mathematical Methods, Econometrics, and Data Science
University Presses, 2026
978-0-691-22180-9
ca. 85.00 CHF
erscheint im April
Copula Models for Dependent Competing Risks
Theory and Applications in Economics, Engineering, Medicine
Taylor and Francis, 2026
978-1-032-85114-3
ca. 85.00 CHF
erscheint im Juli
Probability and Statistics for Engineering and the Sciences, Loose-Leaf Version
Cengage Learning, 2026
979-8-214-02489-9
ca. 166.00 CHF
Lieferzeit unbestimmt